Pharvaris officer to sell $218.8K in stock

Available on EDGAR 09/21/2026 - 04:06 PM EDT Accepted by SEC EDGAR 09/21/2026 - 04:06 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) received a notice that officer David Nassif intends to sell up to 6,000 shares of common stock under Rule 144. The shares, held at Morgan Stanley Smith Barney LLC, had an indicated value of $218,800.80 as of September 21, 2026, and are listed on NASDAQ. The stock to be sold is restricted stock originally acquired from the issuer on April 15, 2025, and the notice reports no other Rule 144 sales in the past three months.

Key Figures

Shares to be sold under Rule 144: 6,000 shares Indicated value of shares: $218,800.80 Type of security: Restricted stock, common shares +3 more

6 metrics

Shares to be sold under Rule 144 6,000 shares Common stock of Pharvaris N.V. reported in the Form 144 notice

Indicated value of shares $218,800.80 Total value of 6,000 common shares as of September 21, 2026

Type of security Restricted stock, common shares Listed in the Securities To Be Sold section

Acquisition date of restricted stock April 15, 2025 Date the restricted stock was acquired from the issuer

Trading market NASDAQ Listing market for Pharvaris N.V. common stock in the filing

Planned sale date reference September 21, 2026 Date associated with the securities information in the notice

Key Terms

Rule 144, Restricted Stock, Securities To Be Sold, Securities Sold During The Past 3 Months, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 04/15/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

NASDAQ market

"09/21/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for PHVS?

The filing discloses that officer David Nassif intends to sell up to 6,000 shares of Pharvaris N.V. (PHVS) common stock under Rule 144, with an indicated value of $218,800.80 as of September 21, 2026.

How many Pharvaris (PHVS) shares are covered by this Rule 144 notice?

The notice covers up to 6,000 shares of Pharvaris N.V. common stock. These shares are reported as restricted stock and are planned for sale under Rule 144.

What is the reported value of the PHVS shares in this Form 144?

The 6,000 Pharvaris (PHVS) common shares have a reported value of $218,800.80 as of September 21, 2026, based on the information in the Form 144 filing.

When and how were the PHVS shares to be sold acquired?

The shares to be sold were acquired on April 15, 2025 as restricted stock from the issuer, Pharvaris N.V. This acquisition detail is listed in the “Securities To Be Sold” section.

On which market are the Pharvaris (PHVS) shares in this filing listed?

The Pharvaris N.V. common stock referenced in this Form 144 is listed on NASDAQ, as stated in the securities information section of the filing.

Were there any Pharvaris (PHVS) shares sold under Rule 144 in the past three months?

The Form 144 indicates no securities sold during the past three months under Rule 144 for the account of David Nassif that are reported in this notice.

Which broker is listed for the planned PHVS share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, at 1 New York Plaza, New York, as the broker handling the planned sale of Pharvaris (PHVS) shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001636975
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	DAVID NASSIF
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	218800.80	70204506	09/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2025	Restricted Stock	Issuer			6000	04/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David W Nassif
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)